This page collects WhisperX intelligence signals tagged #Regulatory. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
The European Medicines Agency (EMA) has accepted the marketing authorization application for taletrectinib, a targeted therapy for non-small cell lung cancer (NSCLC) developed by Nuvation Bio and Eisai. This regulatory milestone signals a critical step forward for the drug's potential entry into the European market, pl...
Caribou Biosciences' stock price surged following a critical regulatory milestone. The U.S. Food and Drug Administration (FDA) granted its CB-010 therapy a Regenerative Medicine Advanced Therapy (RMAT) designation. This status is reserved for regenerative medicine therapies, including cell therapies like CAR-T, that de...
GSK has abruptly withdrawn its application to the U.S. Food and Drug Administration for an autism spectrum disorder drug, a candidate that had previously received high-profile backing from former President Donald Trump. The withdrawal comes just weeks after the pharmaceutical giant submitted the application, signaling ...